Phio Pharmaceuticals Corp. (PHIO)
NASDAQ: PHIO · Real-Time Price · USD
0.9851
-0.0149 (-1.49%)
At close: Oct 2, 2026, 4:00 PM EDT
1.000
+0.015 (1.51%)
After-hours: Oct 2, 2026, 4:19 PM EDT
Phio Pharmaceuticals Market Cap
Phio Pharmaceuticals has a market cap or net worth of $11.44 million as of October 2, 2026. Its market cap has decreased by -17.42% in one year.
Market Cap
11.44M
Enterprise Value
-1.55M
1-Year Change
-17.42%
Ranking
Category
Stock Price
$0.99
ChartMarket Cap Chart
Since May 10, 2012, Phio Pharmaceuticals's market cap has decreased from $16.22M to $11.44M, a decrease of -29.45%. That is a compound annual growth rate of -2.39%.
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2026 | 11.44M | 1.25% |
| Dec 31, 2025 | 11.30M | 262.46% |
| Dec 31, 2024 | 3.12M | 67.92% |
| Dec 29, 2023 | 1.86M | -63.48% |
| Dec 30, 2022 | 5.08M | -62.43% |
| Dec 31, 2021 | 13.53M | -12.96% |
| Dec 31, 2020 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2019 | Upgrade Pro | Upgrade Pro |
| Dec 31, 2018 | Upgrade Pro | Upgrade Pro |
| Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
| Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Related Stocks
| Company | Market Cap |
|---|---|
| Vyome Holdings | 13.55M |
| IN8bio | 13.11M |
| Daré Bioscience | 13.05M |
| Lisata Therapeutics | 12.98M |
| Lantern Pharma | 12.91M |
| Pluri | 12.34M |
| GT Biopharma | 11.67M |
| BioVie | 11.46M |